Intralesional PV-10 Chemoablation of Metastatic Melanoma
Clinical trial NCT00219843 · COMPLETED
Trial details
- NCT number
- NCT00219843
- Sponsor
- Provectus Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.